The center operates as a private healthcare facility that combines clinical practice with scientific research. It serves a global patient base, offering regenerative medicine therapies designed to address conditions often considered difficult to treat with conventional Western medicine. EmCell?s primary focus is on the transplantation of fetal stem cells?progenitor cells harvested from aborted fetuses?which they claim possess superior regenerative potential compared to adult stem cells.
Core Technology: Fetal Stem Cell Transplantation
The fundamental service offered by EmCell is Fetal Stem Cell Transplantation (FSCT). Unlike clinics that utilize autologous stem cells (harvested from the patient's own fat or bone marrow) or umbilical cord cells, EmCell utilizes stem cells derived from fetal tissue.
The Mechanism
The company's proprietary methodology involves the use of cell suspensions containing multipotent stem cells. According to EmCell?s clinical philosophy, these fetal cells are immunologically immature, meaning they lack the specific protein markers that typically trigger rejection in a recipient's body. Consequently, the clinic asserts that their treatments do not require histocompatibility matching or the use of immunosuppressive drugs.
Once administered into the patient's body (typically via intravenous or subcutaneous injection), these cells are intended to migrate to areas of damage or disease, where they engraft and differentiate into the specific cell types needed for repair (e.g., neurons, cardiomyocytes, or beta cells).
Products and Therapeutic Services
EmCell offers comprehensive treatment programs that are tailored to specific medical conditions. These programs generally include diagnostic screening, the stem cell transplantation procedure, and post-treatment monitoring.
1. Neurological Disorders
A significant portion of EmCell's practice is dedicated to treating neurodegenerative and developmental conditions.
* Autism Spectrum Disorder (ASD): The clinic offers a multi-day treatment protocol for children with autism. The therapy aims to improve cognitive function, speech, social interaction, and attention span by repairing neural connections and reducing neuroinflammation.
* Multiple Sclerosis (MS): Treatments focus on remyelination and immune system modulation to slow disease progression and alleviate symptoms like fatigue and spasticity.
* Amyotrophic Lateral Sclerosis (ALS): While not a cure, the therapy is offered as a supportive measure to potentially slow muscle atrophy and extend survival.
* Cerebral Palsy & Parkinson?s Disease: Protocols are designed to stimulate the regeneration of damaged nervous tissue and improve motor functions.
2. Endocrine and Metabolic Diseases
- Diabetes Mellitus (Types 1 and 2): EmCell provides therapies intended to regenerate pancreatic beta cells, improve insulin sensitivity, and reduce the risk of diabetic complications such as neuropathy, retinopathy, and nephropathy.
- Hashimoto's Thyroiditis: Treatments aim to modulate the autoimmune response affecting the thyroid gland.
3. Anti-Aging and General Rejuvenation
EmCell markets a "Revitalization" program aimed at healthy individuals or those suffering from chronic fatigue.
* Anti-Aging Therapy: This service is designed to improve physical capacity, mental acuity, skin elasticity, and libido. It is marketed as a preventative measure to slow the biological aging process and boost the immune system.
4. Cardiovascular Diseases
The clinic treats conditions such as chronic heart failure and ischemic heart disease. The therapy is intended to stimulate angiogenesis (formation of new blood vessels) and improve the pumping function of the heart muscle.
5. Specialized Treatments
- Duchenne Muscular Dystrophy: EmCell holds patents related to the treatment of muscular dystrophies, aiming to slow muscle wasting.
- Infertility and Erectile Dysfunction: Programs focused on restoring reproductive health and hormonal balance.
Clinical Facilities and Infrastructure
EmCell operates a self-contained medical complex in Kyiv that supports the entire lifecycle of their stem cell products, from harvesting to administration.
Biotechnological Laboratory
The center maintains an on-site, GMP-compliant (Good Manufacturing Practice) biotechnological laboratory. This facility is responsible for:
* Preparation: Processing fetal tissues into stable cell suspensions.
* Testing: Conducting rigorous safety screenings for viral, bacterial, and fungal infections (including HIV, Hepatitis, CMV, and Syphilis) to ensure the safety of the biological material.
* Viability Assessment: Testing cell count and viability before clinical use.
The Cryobank
EmCell owns and operates a specialized cryobank that stores over 20,000 samples of fetal stem cell suspensions. These samples are preserved in liquid nitrogen at extremely low temperatures (-196?C). The extensive inventory allows the clinic to select specific cell lines (e.g., precursors of liver cells, nervous tissue, or hematopoietic cells) that are most appropriate for a patient's specific diagnosis.
Clinical Department
The patient care facility is equipped for both diagnostic and therapeutic procedures. Services provided on-site include:
* Ultrasound diagnostics
* Electrocardiography (ECG) and Spirography
* Laboratory testing (blood work, hormonal panels)
* Comfortable wards for day-stay or short-term inpatient care during the administration of cells.
History and Leadership
EmCell was founded by Professor Alexander Smikodub (1948?2009), a pioneer in the field of clinical stem cell transplantation. Professor Smikodub is credited with developing the methods for preparing and preserving fetal stem cell suspensions that the clinic still uses today. Under his leadership, the clinic began treating patients in the mid-1990s, initially focusing on hematological conditions like aplastic anemia before expanding to a wider range of pathologies.
The clinic continues to publish research in medical journals and holds several patents in Ukraine related to the treatment of autism, diabetes, and other chronic conditions using their proprietary stem cell preparations.
